Peptides in oral care: An emerging frontier in remineralization
Key Highlights
- Biomimetic peptides may support enamel remineralization by influencing mineral formation and organization through mechanisms inspired by natural enamel development.
- Emerging peptide and nano-hydroxyapatite technologies are being investigated for early carious lesions and new approaches to preventive oral care.
- Early laboratory findings for KeraHAP showed greater measured remineralization than two comparison products under specific in vitro conditions, though further research is needed to establish clinical effectiveness.
Dental professionals have discussed remineralization for decades, but emerging science is expanding the conversation. Advanced peptide technology is now entering dentistry, shifting the focus from simply delivering minerals to potentially influencing where and how mineralization occurs.
Peptides are not a single technology. Thousands of peptide sequences exist, with activities determined by their structure, concentration, and delivery system. Some act as signaling molecules, while others are being investigated for antimicrobial, regenerative, and mineral-forming applications.
The connection to enamel begins with amelogenesis, the natural process of enamel formation. During this process, extracellular matrix proteins—including amelogenin—help regulate the nucleation, orientation, and organization of hydroxyapatite crystals. These mechanisms have led researchers to investigate whether selected peptides can reproduce aspects of natural mineralization.
What research is showing
In 2025, researchers at King’s College London demonstrated that peptides could support organized apatite nanocrystal formation and produce a mineralized structure with enamel-like characteristics.
Another important area involves the self-assembling peptide P11-4, which has been studied for early carious lesions. Under appropriate conditions, P11-4 can self-assemble within a lesion, creating a three-dimensional matrix that supports mineral formation. This technology has been evaluated in randomized clinical trials and systematic reviews.
These findings do not mean that all peptides function identically. Instead, they demonstrate that specific peptides may be selected or engineered to perform specific biological functions.
Combining peptides and mineral technology
Nano-hydroxyapatite has already introduced a biomimetic approach to oral care. It is the primary mineral component of enamel and supplies calcium-phosphate particles designed to interact with the tooth surface.
The emerging question is what may happen when peptide and mineral technologies are combined.
Consider a brick-and-mortar analogy: nano-hydroxyapatite provides mineral building blocks, while selected peptides may help influence mineral nucleation, organization, or deposition. This is an analogy—not a universal mechanism. Different peptides behave differently, and evidence involving one peptide cannot automatically be applied to another.
A new generation of oral care
One example is Dr. Jen’s KeraHAP™, a fluoride-free toothpaste combining naturally derived biomimetic peptides with nano-hydroxyapatite.
KeraHAP represents a different approach to exploring how biomimetic peptides and nano-hydroxyapatite may work together in an everyday oral-care formulation.
Early laboratory findings are encouraging. In a four-week in vitro study using human enamel specimens subjected to daily acid challenges, KeraHAP demonstrated 62% higher measured remineralization than MI Paste and 78% higher measured remineralization than an over-the-counter fluoride toothpaste under the experimental conditions evaluated.
What does this mean for patient care?
Fluoride remains one of dentistry’s most extensively researched approaches to caries prevention. However, emerging peptide and peptide-enhanced nano-hydroxyapatite technologies may expand the remineralization options available to patients—particularly those at elevated caries risk who choose not to use fluoride.
Dental professionals should continue emphasizing the fundamentals of caries prevention, including diet, salivary function, effective oral hygiene, and regular dental care.
The beginning, not the conclusion
Peptide technologies represent distinct approaches to biomimetic mineralization and should not be treated as interchangeable.
What connects them is a broader scientific movement: learning from the biological processes that create mineralized tissues and investigating whether aspects of those processes can be incorporated into preventive and regenerative dental materials.
Peptides represent an emerging field that may change how dental professionals think about remineralization. The question may no longer be simply, “How much mineral can we deliver?” but “Can biology teach us how to use that mineral more effectively?”
Editor's note: This article appeared in the November/December 2026 print edition of RDH magazine. Dental hygienists in North America are eligible for a complimentary print subscription. Sign up here.
Selected published research
- Gamea S, Radvar E, Athanasiadou D, et al. Biomimetic mineralization of keratin scaffolds for enamel regeneration. Adv Healthc Mater. 2025;14(30):e02465. doi:10.1002/adhm.202502465
- Bröseler F, Tietmann C, Bommer C, Drechsel T, Heinzel-Gutenbrunner M. Randomised clinical trial investigating self-assembling peptide P11-4 in the treatment of early caries. Clin Oral Investig. 2020;24(1):123-132. doi:10.1007/s00784-019-02901-4
- Alkilzy M, Tarabaih A, Santamaria RM, Splieth CH. Self-assembling peptide P11-4 and fluoride for regenerating enamel. J Dent Res. 2018;97(2):148-154. doi:10.1177/0022034517730531
- Aparna BK, Yashoda R, Manjunath PP. Remineralization of early enamel caries lesions using self-assembling peptides P11-4: systematic review and meta-analysis. J Oral Biol Craniofac Res. 2022;12(3):324-331. doi:10.1016/j.jobcr.2022.03.012
- Shaalan O, El-Sayed KF, Abouauf E. Evaluation of the remineralization potential of self-assembling peptide P11-4 with fluoride compared to fluoride varnish in the management of incipient carious lesions: a randomized controlled clinical trial. Clin Oral Investig. 2024;28(8):438. doi:10.1007/s00784-024-05822-z
About the Author
Jennifer Eisenhuth, DDS, MS, PA
Jennifer Eisenhuth, DDS, MS, PA, studied engineering at the University of Minnesota Institute of Technology before dental school and a two-year orthodontic residency. She's also been a faculty member at the University of Minnesota Dental School. Above all, she's a mother. Her search for a healthier, more effective toothpaste for her ill child created Dr. Jen Oral Care. With her children, Dr. Claudia and Dr. Gabe, she built America's most advanced nano-hydroxyapatite brand.


